Cortex Pharmaceuticals, Inc. (AMEX: COR), a biopharmaceutical company, is focused on the discovery, development and commercialization of AMPAKINE molecules designed to treat human central nervous system diseases. These novel small molecule drugs represent usher a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders. For further information, visit the Company’s web site at www.cortexpharm.com.
- 18 years ago
QualityStocks
Cortex Pharmaceuticals, Inc. (AMEX: COR)
Tags Rodman & Renshaw
Related Post
-
Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
In the United States alone, close to one million people are living with MS, with…
-
Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step
California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…
-
Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership
The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…